Skip to main contentSkip to navigation
Sirius Investors
Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc.

KDNY
NASDAQHealthcare

KDNY Financial Statements & Analysis

Complete financial statements for KDNY including income statement, balance sheet, and cash flow statement. Analyze KDNY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
11.2%
Net Income
-13.7%
Gross Margin
4.8%
Operating Margin
-4.9%

Balance Sheet

Current Ratio
-17.3%
Debt to Equity
2.6%
Asset Turnover
23.7%

Cash Flow

Operating Cash Flow
-21.3%
Net Cash Flow
-225.2%
Free Cash Flow
-21.3%
Cash Flow to Debt
-36.6%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q1 '23TTM Q2 '23ChangeImpact
Revenue5.26M5.85M11.2%
Gross Profit3.54M4.12M16.6%
Operating Income-215.69M-251.63M16.7%
Net Income-213.91M-243.21M13.7%
EPS-0.79-0.879.8%
EBITDA-185.89M-220.37M18.5%
Gross Margin67.26%70.49%4.8%
Operating Margin-4101.29%-4302.07%4.9%
Net Income Margin-4067.58%-4158.15%2.2%
R&D Expenses165.84M193.72M16.8%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q2 '23TTM Q1 '23TTM Q4 '22TTM Q3 '22TTM Q2 '22
Revenue5.85M5.26M6.13M
Gross Profit4.12M3.54M4.84M
Operating Income-251.63M-215.69M-185.08M
Net Income-243.21M-213.91M-185.42M
EPS-0.87-0.79-0.72
EBITDA-220.37M-185.89M-155.33M
Gross Margin70.49%67.26%78.97%
Operating Margin-4302.07%-4101.29%-3020.28%
Net Income Margin-4158.15%-4067.58%-3025.80%
R&D Expenses193.72M165.84M141.21M

Our detailed financial analysis helps investors understand KDNY's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track KDNY's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into KDNY's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
Chinook Therapeutics, Inc. (KDNY) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors